Ghanaian e-health startup Redbird has released a consumer app for its health monitoring platform, designed to enable those with chronic illness to more easily and accurately test and monitor their symptoms.
Launched in August 2018, Redbird began offering a platform for in-pharmacy medical testing via rapid tests, and has since seen more than 35 per cent month-on-month growth in registered users and tests performed on their platform.
The startup offers testing for various chronic and acute conditions, and enables pharmacists to track the results of their customers over time, allowing them to create a unique patient profile. This also enables Redbird to help pharmacies manage their stock to ensure patients never face stock-outs and identify real-time population-level prevalence of disease.
Redbird, which secured funding from Gray Matters Capital through GMC coLABS last year, has over 12,000 registered users and has logged 70,000 test results so far, and has now launched a consumer app to make testing even easier. The app will enable end users to access their health data, track the progress of their illness, add results at home, and more easily share their history with their family or doctor for a more informed diagnosis and treatment plan.